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Background: Survivin, a member of the inhibitor of apoptosis (IAP) gene family, has a dual role in mitosis and in
apoptosis. It is abundantly expressed in every human tumor, compared with normal tissues. During mitosis Survivin
assembles with the chromosomal passenger complex and regulates chromosomal segregation. Here, we aim to
explore whether interference with the mitotic function of Survivin is linked to p53-mediated G1 cell cycle arrest and
affects chromosomal stability.
Methods: In this study, we used HCT116, SBC-2, and U87-MG and generated corresponding isogenic p53-deficient
cells. Retroviral vectors were used to stably knockdown Survivin. The resulting phenotype, in particular the
mechanisms of cell cycle arrest and of initiation of aneuploidy, were investigated by Western Blot analysis,
confocal laser scan microscopy, proliferation assays, spectral karyotyping and RNAi.
Results: In all cell lines Survivin-RNAi did not induce instant apoptosis but caused polyplodization irrespective of
p53 status. Strikingly, polyploidization after knockdown of Survivin resulted in merotelic kinetochore spindle
assemblies, γH2AX-foci, and DNA damage response (DDR), which was accompanied by a transient p53-mediated
G1-arrest. That p53 wild type cells specifically arrest due to DNA damage was shown by simultaneous inhibition of
ATM and DNA-PK, which abolished induction of p21waf/cip. Cytogenetic analysis revealed chromosomal aberrations
indicative for DNA double strand break repair by the mechanism of non-homologous end joining (NHEJ), only in
Survivin-depleted cells.
Conclusion: Our findings suggest that Survivin plays an essential role in proper amphitelic kinetochore-spindle
assembly and that constraining Survivin’s mitotic function results in polyploidy and aneuploidy which cannot be
controlled by p53. Therefore, Survivin critically safeguards chromosomal stability independently from p53.
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Among the family of inhibitor of apoptosis proteins
(IAPs), Survivin has received vast attention because it is
highly expressed in cancer tissues and cancer cell lines
[1,2]. The gene for Survivin, birc5, is located in 17q25,
and gives rise to a dominant expressed isoform with a
molecular weight of 16.5 kDa [1]. Compared to other
IAPs involved in apoptosis inhibition, Survivin is devoid
of C-terminal RING finger and contains only one bacu-
loviral IAP repeat (BIR) domain [1,3]. First attempts to* Correspondence: Achim.Temme@uniklinikum-dresden.de
1Department of Neurosurgery, Section Experimental Neurosurgery/Tumor
Immunology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstr.
74, 01307 Dresden, Germany
Full list of author information is available at the end of the article
© 2014 Wiedemuth et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.elucidate the molecular function of Survivin demonstrated
an anti-apoptotic function mediated by its BIR domain
[4-7]. Although Survivin originally has been described to
inhibit apoptosis by blocking activated caspases [7,8] and
smac/Diablo [9], it is now unanimously recognized that
the main molecular function of Survivin is linked to the
control of the spindle assembly checkpoint (SAC) and
cytokinesis [10]. The mitotic localization of Survivin is
consistent with proteins described as chromosomal pas-
senger proteins (CPP) [11-13]. During early mitosis, Survi-
vin associates around centromeres together with its CPP
partners Aurora B, Borealin and inner centromere protein
(INCENP) to build a chromosomal passenger complex
(CPC) [12,14]. At this location the CPC is responsible forntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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interaction [15-17]. It is hypothesized that the CPC can
resolve the problem of syntelic- or merotelic-attached
chromosomes by freeing the microtubule-kinetochore
assembly, which eventually leads to the activation of the
spindle assembly checkpoint (SAC) and therefore pre-
vents premature onset of anaphase [18-20]. When ana-
phase starts Survivin leaves the kinetochores but in
telophase re-aggregates with its CPC partners at the
polar end of microtubules demarcating the cleavage fur-
row [21,22]. At this location, the Aurora B kinase within
the CPC phosphorylates proteins regulating the con-
tractile actin-myosin ring such as MGCRacGAP [23].
Cells with impaired function of Survivin or of one of its
CPP partners due to RNAi-mediated inhibition or expres-
sion of dominant-negative mutants showed comparable
phenotypes (i.e., disturbed segregation of chromosomes
and defective cytokinesis) [5,21,24-26].
Many reports focused on the role of Survivin’s IAP func-
tion in the control of p53-governed cell cycle checkpoints
and induction of apoptosis. Early studies using HCT116
cells and HCT116p21−/− cells revealed that interfering mi-
tosis with a SurvivinC84A mutant led to polyploidy and
increased cell death in both cell lines [5]. However, the
isogenic cells with knockout of the cell cycle regulator
p21waf/cip showed an even greater fraction of polyploid
cells containing more nuclei per cell. From the observa-
tion that p21waf/cip colocalized with Survivin and activated
caspase 3 in centrioles of HCT116 wild type cells trans-
fected with a Survivin C84A mutant, and experiments
showing p21waf/cip cleavage after Survivin antisense-
treatment, it was inferred that this CDK inhibitor might
be regulated by the IAP-function of Survivin. In addition,
the inactivation of Survivin by antisense or dominant-
negative SurvivinT34A resulted in increased mdm2 cleav-
age in MCF-7 cells leading to accumulation of p53 and
cell death [27]. Another study observed an increase in
p21waf/cip protein levels after interference with Survivin
function which was accompanied by activation of p53
[28]. Additionally, Survivin knockout in mouse thymo-
cytes triggered a p53-mediated growth arrest but resulted
in a p53-independent cell death [29].
So far it has been shown by various methods that the
loss of Survivin function severely affects cell division. Yet,
it has remained largely unclear why loss of Survivin in
some cell lines leads to activation of p53, subsequent
p21waf/cip mediated cell cycle arrest and eventually causes
cell death.
In this study, we decipher the direct effects but also a
subordinate phenotype after Survivin RNAi in three dif-
ferent cell lines and their p53-deficient isogenic counter-
parts. Our results support published conclusions about
Survivin’s function as a chromosomal passenger protein
and uncovers the induction of an ATM and DNA-PKCSmediated DNA damage response (DDR) after knock-
down of Survivin in p53-deficient cells and wild type
cells. Interestingly, cells with knockdown of Survivin de-
veloped polyploidy accompanied by the appearance of
merotelic kinetochore-microtubuli assemblies in mitosis
eventually resulting in DNA double strand breaks. Yet,
cells managed to repair damaged chromosomes by non-
homologous end joining recombination (NHEJ) resulting
in aberrant chromosomes.
The appearance of merotelic kinetochore-microtubuli
assemblies, chromosomal breaks and, the induction of
DDR as well as the activation of p53 and induction of
p21waf/cip in cells with knockdown of Survivin displaying
high grade polyploidy conclusively proves that an induc-
tion of a p53-dependent G1-arrest is a consequence of
heavily disturbed mitosis. In conclusion, our results high-
light the important role of Survivin as a chromosomal
passenger protein which in concert with its molecular
partners Aurora B, INCENP and Borealin, protects cells
independently from p53 function from polyploidy and
chromosomal instability.
Results
Knockdown of Survivin leads to a p53-independent
development of polyploid cells
In order to corroborate the relationship between Survivin
and p53 and its downstream effector p21waf/cip we ana-
lyzed the impact of Survivin knockdown on a panel of
three cell lines with loss of p53 function and their iso-
genic p53-positive counterparts. We used HCT116p53−/−
colorectal carcinoma cells, and also newly generated
SBC-2shp53 and U87-MGshp53 cells with a shRNA-
mediated stable knockdown of p53. As controls served
HCT116 wild type cells and isogenic U87-MG, SBC-2
cells transduced with a shRNA targeting firefly luciferase.
Western blot analyses revealed an efficient knockdown of
p53 in U87-MG and SBC-2 cells and demonstrated the
accumulation of p53 in shLuc cells following treatment
with the DNA-damaging drug doxorubicin (see Additional
file 1). After knockdown of Survivin we detected in all six
cell lines significant polyploidization and multipolar spin-
dles in mitosis whereas all cell lines transduced with the
control shRNA remained unaffected (Figure 1a, b). Inter-
estingly, there were no major differences in the amount of
cells displaying genomes >4n after Survivin-RNAi when
comparing p53 wild type and p53-deficient cells in U87-
MG and HCT116 cells and higher than 6n in SBC-2 cells
(triploid cell line) (Figure 1c). Yet, we constantly observed
that the grade of polyploidy was higher in p53-deficient
cell lines when compared to p53-positive controls indicat-
ing a faster cell cycle progression rate (Figure 1b). When
we tested the expression of p53 in Western blot analysis it
became obvious that wild type cells accumulated p53 after
Survivin-RNAi whereas HCT116p53−/−, U87-MGshp53, and
Figure 1 Knockdown of Survivin leads to polyploidy in p53-positive tumor cells and isogenic cell lines deficient for p53. HCT116, SBC-2,
U87-MG and isogenic HCT116p53−/−, SBC-2shp53, and U87-MGshp53 cells were transduced with shRNAs targeting Survivin (shSurv) or Luciferase
(shLuc). a: Representative indirect-immunofluorescence images of transduced SBC-2 cells. The shLuc-transduced cell shows a normal bipolar
spindle formation in anaphase. The shSurv-transduced cell shows multipolar spindles and increased numbers of chromosomes. Microtubules
(green), membranes (red) and chromosomes (blue). Magnification bars: 10 μm. b: FACS-analyses of cells with knockdown of Survivin depicting
the appearance of polyploid cells in wild type and p53-deficient cells. c: Quantitative analysis of the polyploidy phenotype (i.e. cells with DNA
contents >4n or >6n for SBC-2) of HCT116, U87-MG and SBC-2 and corresponding p53-negative cells. Data represents mean values and standard
error of the mean (SEM). d: Western blot analysis of whole cell lysates demonstrating knockdown of Survivin and accumulation of p53 in
Survivin-depleted HCT116, U87-MG and SBC-2 wild type cells but not in controls (shLuc) or p53-deficient cells.
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(Figure 1d). These results indicate that the polyploidy fol-
lowing Survivin-RNAi is independent from p53 function,
although Survivin-RNAi affects the steady state levels of
p53 in wild type cell lines.
The gradual increase in polyploidy in tumor cells with
knockdown of Survivin is accompanied by activation of
p53 and increased p21waf/cip expression levels
Since it was of special interest whether stable loss of
Survivin protein is compatible with life we performed
clonogenic survival assays. Notably, all cell lines with
stable knockdown of Survivin showed after a cultivation
period of 3 weeks a dramatic decrease in clonogenic sur-
vival irrespective of p53 status when compared to shLuc-
transduced cell lines (see Additional file 2a). Interestingly,
after knockdown of Survivin no activation of effector
caspase 3 was observed in p53-positive HCT116 and
U87-MG as well as in p53-negative HCT116shp53 and
U87-MGshp53 cells, respectively (see Additional file 2b, c).
However, when we assessed gross fragmentation of
DNA it became obvious, that cell populations with knock-
down of Survivin contained increased fractions of cells
with hypodiploid DNA content when compared to shLuc
controls (see Additional file 2d). Yet further AnnexinV/propidium iodide stainings at time points 24 h, 48 h after
RNAi showed no significant difference in the fraction of
apoptotic cells irrespective of p53 status when shSurv cells
were compared to shLuc-transduced controls. Only at
72 h after Survivin-RNAi we observed an increase in the
fraction of dead cells and a negligible increase in the frac-
tion of apoptotic cells when compared to the shLuc con-
trols which again was independent from p53 status (see
Additional file 2e, f ). In conclusion in our experimental
setting knockdown of Survivin did not result in an apop-
totic phenotype.
When we analyzed total cell lysates of U87-MG cells it
became apparent that the knockdown of Survivin, be-
sides the increase of p53 steady state expression, caused
an induction of p21waf/cip (Figure 2a), whereas U87-
MGshp53 cells were not affected. In addition, a concomi-
tant increase in the protein expression levels of Cyclin D1
and Cyclin E indicated a G1 cell cycle arrest in p53-
positive U87-MG cells following Survivin-RNAi (Figure 2a).
Interestingly, we also observed a slight increase in Cyclin
D1 and Cyclin E protein expression levels after knockdown
of Survivin in U87-MGshp53 cells, suggesting an attenuated
cell cycle progression independent from p53 function. In
order to assess whether an activation of the p53/p21waf/cip
axis occurs as an immediate effect or develops together
Figure 2 Accumulating DNA contents after knockdown of Survivin leads to transient cell cycle arrest in p53-positive tumor cells.
a: Western blot analysis of U87-MG glioma cells and U87-MGshp53 72 h after transduction of a shRNA targeting Survivin demonstrating an increase
in steady state protein levels of p53, p21waf/cip. The increase in Cyclin D1 and Cyclin E protein levels in p53-positive wild type cells indicate a cell
cycle arrest. A p21waf/cip–mediated cell cycle arrest is not observed in shLuc-transduced control cells or in isogenic U87-MGshp53 cells with
knockdown of Survivin. Red values depict densitometric estimation of protein levels, normalized to Tubulin. b: Western blot analysis and parallel
DNA-analysis of HCT116 cells at different time points after RNAi showing a gradual increase in p53, p21waf/cip, Cyclin D1 and Cyclin E protein levels
only in p53-positive cells (wt) after knockdown of Survivin but not in corresponding HCT116p53−/− cells and shLuc controls. c: DNA analyses of
HCT116 and HCT116p53−/− after transduction showing time-dependent gradual increase in polyploidy in Survivin-depleted cells. The amount of
DNA content (n) in the cell fractions is indicated.
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lel the cell cycle and expression of cell cycle proteins of
HCT116 wild type and HCT116p53−/−-cells at different
time points after RNAi (Figure 2b, c). In line with previ-
ously published data showing inhibitory effects of p53 on
Survivin transcription [30,31] we found decreased Survivin
protein steady state levels in shLuc-transduced HCT116
wild type cells when compared to shLuc-transduced
HCT116p53−/− cells at all investigated time points
(Figure 2b). Yet, in the aforementioned U87-MG cells we
did not find decreased expression levels of Survivin in
U87-MG cells when compared to U87-MGshp53−/− cells
which is likely caused by mdm2-augmented degradation
of p53 in those PTEN-negative cell lines [32].
The knockdown of Survivin in HCT116p53−/−-cells re-
vealed, as expected, no signs of p53 expression or induc-
tion of p21waf/cip, but an increase in the grade of polyploidy
over time. Furthermore, it only weakly increased CyclinD1 expression and did not alter the expression levels of
Cyclin E when compared to the shLuc-transduced con-
trols. In HCT116 wild type cells the knockdown of Sur-
vivin clearly demonstrated a time-dependent increase in
the accumulation of p53 protein as well as a gradual in-
crease in expression levels of p21waf/cip (Figure 2b). Fur-
thermore, progressively increased Cyclin D and E protein
levels indicate a G1 arrest. In conclusion these results
show a time-dependent increase of markers of G1 cell
cycle arrest in p53-positive cells after knockdown of
Survivin which was paradoxically accompanied by an
ongoing endoreplication of the genome leading to the
development of HCT116 cells bearing genomic DNA
contents in the range of 4n to 32n (Figure 2c). Yet,
the question arises why p53-positive cells with knock-
down of Survivin display molecular signs of a G1 cell
cycle arrest, but are still capable of replicating their
genomes.
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p21waf/cip-mediated cell cycle arrest and attenuates
S-phase entry
In order to address the above mentioned question and
to correlate the grade of polyploidy (4n and higher) of
the cells directly to regulators of the cell cycle and
DNA-synthesis we employed a simultaneous BrdU-
incorporation/DNA-staining protocol as well as con-
comitant DNA/p21waf/cip, and DNA/Cyclin D1 staining
protocols for flow cytometry. Interestingly, an increase
in p21waf/cip (Figure 3a, b) as well as Cyclin D1-positive
cell fractions (Figure 3d, e) after knockdown of Survivin
showed a significant and direct correlation with increas-
ing polyploidy in p53-positive HCT116 cells when com-
pared to isogenic p53−/−-cells (p < 0.01), indicating that
cells containing higher DNA content had a greater prob-
ability of undergoing G1 cell cycle arrest.
When analyzing total cell populations after Survivin-
RNAi it became apparent that the p53-positive cells con-
tain significant increased fractions of p21waf/cip (Figure 3c)
and Cyclin D1-positive cells (Figure 3f) when compared
to p53-positive cells transduced with shLuc control vector
(each p < 0.01) and p53−/−-cells after knockdown of Sur-
vivin, respectively (each p < 0.01). Interestingly, after
knockdown of Survivin in p53−/−-cells we observed a
considerable smaller and significant increase in the frac-
tion of Cyclin D1 positive cells in the whole cell popula-
tion when compared to p53−/−-shLuc controls (p < 0.01),
yet without increase in p21waf/cip expression suggesting a
slight p53-independent effect on cell cycle progression
(Figure 3f).
On the other hand, the BrdU-incorporation analysis
revealed that substantial fractions of p53 wild type cells
as well as p53−/−-cells with knockdown of Survivin were
still able to enter S-phases of cells with DNA contents of
4n and higher (Figure 3g, h). In contrast to Cyclin D1
and p21waf/cip-expression levels we found a significant
decrease in BrdU-incorporation levels in p53-positive cells
when compared to HCT116p53−/− (p < 0.05), which was in-
versely correlated to increase in polyploidy (Figure 3g).
When we compared the BrdU incorporation levels of
the total cell populations we revealed a significant de-
crease in the BrdU-positive cell fraction of p53-positive
cells with knockdown of Survivin compared to shLuc
controls (p < 0.05) and even to p53−/−-cells with knock-
down of Survivin (p < 0.05) (Figure 3i).
In conclusion, these results demonstrate an associ-
ation of Survivin-RNAi-induced polyploidy with p53 ac-
tivation and induction of p21waf/cip. However, p53
activation and induction of p21waf/cip after knockdown
of Survivin did not hinder entry into S-phase, which in-
dicates a transient cell cycle arrest. Yet, the molecular
cause of this observed transient cell cycle arrest remains
obscure.Survivin-RNAi leads to an increase in merotelic spindle
attachments, DNA breaks, induction of a DNA damage
response, and chromosomal instability
A recent study demonstrated an increase in merotelic at-
tachments in multipolar cells [33]. Staining of SBC-2 wild
type cells after knockdown of Survivin with anti-tubulin
and anti-centromere-antibodies (ACA) revealed multiple
spindles with spindle fibers bound to diverse aligned meta-
phase chromosomes, thereby causing merotelic and more-
over poly-merotelic (arising from multiple spindle poles)
connections to chromosomes (Figure 4, and see Additional
file 3). In particular, in cells with higher polyploidy kineto-
chores of sister chromatids bound to spindles emanating
from several spindle poles were constantly observed (see
dodecaploid cell in Figure 4).
Since non-resolved merotelic attachments can cause
chromosomal breaks and subsequently a DNA damage
response [34], we hypothesized that the observed high
abundance of merotelic attachments due to the knock-
down of Survivin might be linked to the activation of
p53 and its downstream effector p21waf/cip. In order to
detect probable resulting chromosomal breaks on the
molecular level we analyzed the expression of γH2AX, a
marker for DNA-double strand breaks (DSB) in SBC-2
p53-positive cells and SBC-2shp53-cells after Survivin-
RNAi. By using indirect immunofluorescence analysis
and quantification of γH2AX positive cells it became
obvious, that a significant fraction of cells had definitely
acquired DNA-damages after knockdown of Survivin ir-
respective of p53 status (mean ± SEM, wt/shLuc: 2.4% ±
2.7%; wt/shSurv: 43.0% ± 9,5%, p < 0.01; shp53/shLuc:
4,8% ± 5,1%; shp53/shSurv: 40,8%± 5.9%, p < 0.01) (Figure 5a,
b). The observed γH2AX foci were 1 to 3 μm in diam-
eter and appeared only in multinucleated cells marking
a moderate number of DNA lesions per cell (1 to 5
DSB/cell) (Figure 5a). As expected, a significant in-
creased nuclear expression of p21waf/cip after Survivin-
RNAi, indicative of a cell cycle arrest, was only observed
in p53 wild type cells when compared to SBC-2shp53
cells (p < 0.01)(Figure 5b). Furthermore, quantitative
analysis of SBC-2 p53 wild type cells revealed that about
50% of γH2AX-positive cells (mean ± SEM, wt/shSurv:
51.4% ± 11.5%) showed induction of p21waf/cip, as detected
in the nuclei of cells. On the other hand SBC-2shp53 cells
(mean ± SEM, shp53/shSurv: 17.2% ± 12.3%) showed sig-
nificantly less (p < 0.01) p21waf/cip signals in γH2AX-
positive nuclei (Figure 5c).
In line with these results additional FACS-assisted ana-
lysis of γH2AX expression confirmed increased γH2AX
expression preferentially in polyploid HCT116p53−/− and
corresponding isogenic p53-positive cells after knock-
down of Survivin whereas transduction of the shLuc
control had no effect on the levels of γH2AX-positive
cells (Figure 5d). DNA damage gradually increased
Figure 3 Increasing DNA contents after Survivin-RNAi are linked to a p53-dependent transient cell cycle arrest and to an attenuated
entry into S-phase. a-c: Combined PI-staining of DNA and p21waf/cip in HCT116 and HCT116p53−/− cells 72 h after transduction of shRNA-vectors.
a: Graph showing the mean values and SEM of p21waf/cip-positive cell fractions after knockdown of Survivin at different DNA contents ranging
from 2n to greater than 8n (**p < 0.01). b: Representative FACS analysis showing p21waf/cip staining in HCT116 (wt) and HCT116p53−/− cells.
c: Quantitative analysis of the induction of p21waf/cip in total HCT116 and HCT116p53−/− cell populations after transduction of shSurv and shLuc
control, respectively (**p < 0.01; n = 4) d-f: Combined PI-staining of DNA and Cyclin D1 in HCT116 and HCT116p53−/− cells after transduction of
shRNA-vectors. d: Graph showing the mean values and SEM of Cyclin D1-positive cell fractions after knockdown of Survivin at different DNA
contents (**p < 0.01). e: Representative FACS dot blots showing Cyclin D1 analyses in HCT116 (wt) and HCT116p53−/− (p53−/−) cells f: Quantitative
analysis of the induction of Cyclin D1 expression in total HCT116 and HCT116p53−/− cell populations after transduction of shSurv and shLuc
control, respectively (**p < 0.01). g-i: BrdU-incorporation analysis. g: Graph showing the mean values and SEM of BrdU-positive cell fractions after
knockdown of Survivin in S-phases of cells (S1 to S3). Note, that despite p21waf/cip and Cyclin D1 accumulations HCT116 cells with DNA
content >4n are still able to incorporate BrdU. h: Representative FACS dot blots showing BrdU stainings after Survivin knockdown. i: Effect of
Survivin knockdown on BrdU incorporation in total HCT116 and HCT116p53−/−cell populations and the corresponding shLuc controls. Data
represents mean values and SEM (*p < 0.05; **p < 0.01).
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of Survivin (Figure 5e).
In order to investigate whether the high number of
observed merotelic and poly-merotelic chromosomalattachment to the spindle apparatus and the resulting
DSBs eventually cause structural chromosomal aberra-
tions, we analyzed HCT116p53−/−-cells using Giemsa
and DAPI staining. Furthermore, we performed spectral
Figure 4 Survivin controls kinetochore-microtubuli attachments. a: Indirect-immunofluorescence images of mitotic SBC-2 wild type cells,
transduced with shLuc or shSurv, respectively. The shLuc-transduced cell shows a normal bipolar spindle assembly during anaphase. The depicted
shSurv-SBC-2 cell is dodecaploid and displays abnormal spindle formation in metaphase with a poly-merotelic connected chromosome
(arrowhead; inset). b: Different angles of a 3D-reconstructed z-stack of the same merotelic attachment shown in a: demonstrating binding of up
to four microtubli from three different directions to a single kinetochore (KTa). MT, microtubuli (red); KT, kinetochore; (yellow); membrane (green).
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the control vector (shLuc) displayed a stable hypodip-
loid karyotype (2n-, chromosome number 45, 44 auto-
somes and one X chromosome) in the SKY analyses
with recurrent chromosomal aberrations described for
the HCT116p53−/− cell line in the NCI and NCBI’s SKY/
M-FISH and CGH Database (2001), (http://www.ncbi.
nlm.nih.gov/sky/skyweb.cgi) including deletion of the
long arm of chromosome 5, unbalanced translocations
between chromosomes 5 and 7, 8 and 16, as well as be-
tween 17 and 18, and a derivative chromosome 10 with
duplication of material of the long arm of chromosome
10 and translocation of material from chromosome 16
(45,X,-Y,t(5;7)(q13;pter), der(10)dup(10)(q23.1q26.1)t(10;16)
(q26.1;q23), der(16)t(8;16)(q13;pter), der(18)t(17;18)(q21.3;
pter)) (Figure 6a). In contrast, in HCT116p53−/− cells
with knockdown of Survivin, the majority of metaphases
analyzed showed a near tetra-, octa-, or even hexadeca-
ploid karyotype (85–91, 151–172, and ~ 300 chromo-
somes per metaphase). Additionally to the chromosomal
aberrations already present in HCT116p53−/− shLuc, SKY-
analysis marked chromosomal instability with additional
structural chromosomal aberrations in all metaphases
analyzed, such as translocations, loss of whole chromo-
somes, dicentric chromosomes, chromosome fragments,
or truncated chromosomes (Figure 6b). Analysis of Giemsa-and DAPI-stained metaphases of HCT116p53−/− shSurv
cells revealed constantly dicentric and ring chromo-
somes, which can occur due to DSB repair (Figure 6c,
and see Additional file 4). No dicentric and ring chro-
mosomes were detected in shLuc-transduced cells.
Moreover, we identified a higher frequency of chromo-
somal breaks in shSurv-HCT116p53−/− cells compared
to HCT116p53−/− shLuc cells (mean breaks/cell for shLuc
0.25; mean breaks for shSurv 1, p < 0.05). So far our data
suggest that knockdown of Survivin causes defective cyto-
kinesis (leading to polyploidy), failures in the SAC, and in-
creased DSBs (leading to chromosomal instability with
structural chromosomal aberrations and aneuploidy).
Survivin-RNAi induced DNA damage response is mediated
through combined action of ATM and DNA-PK sensor
kinases
To analyze the connection between Survivin-RNAi and
the induction of a DNA-damage response (DDR) we fo-
cused on ataxia telangiectasia mutated gene product
(ATM) a sensor kinase involved in DSB repair. By using
confocal laser scanning we detected activated ATM
(ATM S1981) colocalized to γH2AX foci, with a diam-
eter of 1–3 μm, in SBC-2 wild type cells with knock-
down of Survivin (Figure 7a). Cells transduced with the
shLuc control vector never displayed such γH2AX/ATM
Figure 5 (See legend on next page.)
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Figure 5 Knockdown of Survivin results in DNA damage and p53-dependent induction of the cdk-inhibitor p21waf/cip. a-c:
Indirect-immunofluorescence analysis of SBC-2 and SBC-2shp53 cells, transduced with shLuc and shSurv, respectively. a: Representative images of
simultaneous p21waf/cip and ɣH2AX stainings showing ɣH2AX-foci only in polyploid nuclei of shSurv-SBC-2 cells. Magnification bar 50 μm.
b: Quantification of ɣH2AX and p21waf/cip expression. Depicted are the mean values and SEM (n = 3; **p < 0.01). Knockdown of Survivin causes
DNA-damage irrespective of p53 status whereas induction of p21waf/cip is p53-dependent. c: Quantification of ɣH2AX positive cells with
simultaneous p21waf/cip expression. Note the increase in p21waf/cip expression linked to DNA damage in SBC-2 cells with functional p53 (p < 0.01).
d: Representative FACS-analysis showing an increase in ɣH2AX staining in Survivin-depleted HCT116 cells compared to shLuc control, irrespective
of p53-status. e: Distribution of ɣH2AX expression in wild type and HCT116p53−/− cells in dependence of DNA content. The increase in
ɣH2AX-positive cell fractions is independent from p53 status and directly correlates to the gradual increase in polyploidy.
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γH2AX/ATM-foci in shSurv-U87-MG cells (see Additional
file 5). Noteworthy, activated CHK2 phosphorylated at
T68, a downstream target of ATM was colocalized with
γH2AX in SBC-2 cells with knockdown of Survivin (Figure 7c)
whereas no signals were found in shLuc control cells
(Figure 7d).
Our observations suggest that the activation of a tran-
sient p53/p21waf/cip -dependent cell cycle arrest in G1
after Survivin knockdown occurs after mitotic defects
and is linked to the CPP function of Survivin. To verify
that the DDR and not the loss of Survivin’s IAP function
accounts for p53 activation and subsequent induction of
p21waf/cip we generated HCT116 wild type cells with
stable knockdown of ATM. We hypothesized that an in-
activation of ATM should block phosphorylation of p53
by an activated ATM which in turn should abolishFigure 6 Survivin protects cells from chromosomal instability. a: SKY-A
chromosomal aberrations as well as polyploidy) in Survivin-depleted HCT116p
shLuc-transduced HCT116p53−/− cell with hypodiploid (2n-) karyotype 45,X,-Y,t
(q13;pter), der(18) t(17;18)(q21.3;pter) (arrowheads). b: Exemplary karyograms
karyotypes (87,XX), harboring the aberrations found in shLuc, but also additio
(arrow) and loss of two chromosomes 2. Lower karyogram: additional structu
loss of chromosome 13, 19, 21 (arrows). c: DAPI-stained metaphase of HCT116
(16n-) karyotype (360 chromosomes) with dicentric chromosomes (arrows) anp21waf/cip expression. Survivin-RNAi in HCT116 wild
type cells caused, as expected, increased γH2AX protein
expression levels accompanied by increased protein levels
of p53, p53 phosphorylated at Serine 15 (p53pSer15),
p21waf/cip and Cyclin D1 when compared to shLuc control
cells (Figure 8a). Furthermore, as anticipated, we detected
activated ATM (ATM S1981) in these cells. Noteworthy,
ATM S1981 most likely phosphorylates p53 at position
S15 in HCT116 cells with knockdown of Survivin. Besides
this, we also detected its downstream kinase CHK2 phos-
phorylated at T68 [35] (Figure 8a).
Remarkably, the inactivation of ATM in HCT116 cells
(HCT116shATM) resulted after knockdown of Survivin in
a strong decreased CHK2 phosphorylation at Thr68 and
slightly decreased levels of γH2AX. On the other hand,
it did not inhibit the activation of p53 and the subse-
quent induction of p21waf/cip expression, respectively.nalysis reveals chromosomal instability (gain of numerical and structural
53−/− cells 72 h after retroviral transduction. Representative karyogram of
(5;7)(q13;pter), der(10)dup(10)(q23.1q26.1)t(10;16)(q26.1;q23), der(16)t(8;16)
of Survivin-depleted HCT116p53−/− cells showing nearly tetraploid
nal aberrations. Upper karyogram: additional dicentric chromosome 1
ral aberrations del(2)(q13), der(9)t(9;12), der(15)t(15;17), der(20)t(3;20) and
p53−/− cells with knockdown of Survivin showing a hypohexadecaploid
d chromosome breaks (arrowheads).
Figure 7 (See legend on next page.)
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Figure 7 Activation of ATM and CHK2 at DNA lesions in SBC-2 cells with knockdown of Survivin. a: Representative immunofluorescence
analysis of SBC-2 cells, with knockdown of Survivin and stained for activated ATM (ATM S1981) and ɣH2AX. Note double positive ɣH2AX, ATM
S1981 loci indicative for DDR occurring in polyploid nuclei (arrowheads). Inlet showing magnification of indicated multinucleated cell with
colocalized ɣH2AX and ATM S1981. b: Representative image depicting ɣH2AX, ATM S1981 staining in shLuc-transduced controls. Magnification
bars: 10 μm. c: Representative image of SBC-2 cells after knockdown of Survivin showing the appearance of activated CHK2 (CHK2 T68) in
ɣH2AX-positive DNA lesions. d: ɣH2AX and CHK2 T68 do not appear in shLuc-transduced SBC-2 cells. Magnification bars: 10 μm.
Wiedemuth et al. Molecular Cancer 2014, 13:107 Page 11 of 18
http://www.molecular-cancer.com/content/13/1/107Since our cytogenetic analysis revealed chromosomal
translocations, we also investigated the role of DNA
PKCS DNA-sensor kinase, which plays a pivotal role in
DNA repair by the mechanism of non-homologous end
joining (NHEJ). Interestingly, we detected activated
DNA-PKCS colocalized with ATM S1981 positive foci in
nuclei of cells following RNAi of Survivin (Figure 8b). In
line with this Western blot analysis of p53 phosphoryl-
ation sites in shSurv-treated HCT116 cells revealed en-
hanced phosphorylation of p53 at S15, S20 and at
position S37 indicative of activated ATM, CHK2 and
DNA-PKcs kinases [36,37] (Figure 8c). We therefore con-
cluded that the DNA damage response in HCT116shATM
following Survivin-RNAi is also sensed and initiated
by DNA-PK (see proposed sensor kinase signaling in
Figure 8d). To conclusively prove that loss of Survivin
CPP function (in controlling cytokinesis and SAC) is
responsible for a transient cell cycle arrest we simul-
taneously blocked ATM (by stable RNAi) and DNA-
PKCS (using the specific inhibitor Nu7026) upstream
of p53 and p21waf/cip. As depicted in Figure 8e only
the combined inhibitions of both DNA damage sensor
kinases led to a decrease in phosphorylation of p53 and
subsequently to significantly decreased p21waf/cip protein
levels. In particular, simultaneous inhibition of DNA-PKcs
and ATM lead to a weaker decrease in S15 phosphoryl-
ation but strongly abrogated p53 phosphorylation at S20
and S37 and reduced protein levels of γH2AX. These re-
sults corroborate the involvement of DNA-PKCS and
ATM in the induction of the p53/p21waf/cip mediated tran-
sient cell cycle arrest, DSB repair and NHJE in cells with
knock down of Survivin.
Discussion
The RNAi-phenotype of Survivin confirms its role as
chromosomal passenger protein and uncovers its
essential role in DNA integrity
Precise chromosome segregation during mitosis requires
the attachment of chromosomes to microtubules eman-
ating from both poles of the spindle apparatus. Non-
attachment of spindles to kinetochores is sensed by
mitotic SAC proteins including CENP-E, Bub1, BubR1,
Bub3, Mad1, Mad2 and Mps1. Although not all interac-
tions of SAC proteins are fully understood, it is generally
accepted that Mad2 represents the effector protein in
charge that becomes activated at kinetochores. Mad2inhibits the anaphase promoting complex/cyclosome
(APC/C) by direct binding to Securin and Cyclin B,
whose degradation is required for onset of anaphase
[38,39]. Yet, during the stochastic attachment process of
spindle-kinetochore binding, all but bipolar attachments
need to be resolved to allow new rounds of attachments.
Bipolarity of spindle kinetochore attachment is subjected
to pulling forces of the mitotic spindle which is opposed
by cohesion between the sister chromatids. Today it is
generally suggested, that the CPC, especially its kinase
Aurora B, cuts off microtubule binding due to lack of
tension on the kinetochores [17,20]. This in turn leads
to free kinetochores which activate the mitotic SAC [40]
and allows a new round of kinetochore microtubuli
attachments.
Our study confirmed that Survivin is essentially
needed for cytokinesis but also for proper regulation of
bipolar spindle attachment. Noteworthy, Survivin is not
controlling cell cycle arrest as revealed by our spatial
and temporal analysis of the developing Survivin-RNAi
phenotype. We conclusively corroborate that the induc-
tion of a transient G1 arrest is a consequence of heavily
disturbed mitosis, which is solely linked to Survivin’s
role as CPP as discussed in detail below. Furthermore,
cell death after knockdown of Survivin was not accom-
panied with increased levels of activated Caspase 3 or in-
crease in the fraction of annexin V-positive cells but was
linked to the gradual increase in polyploidy. This obser-
vation is consistent with other reports describing a mi-
totic catastrophe after interference with the function of
Survivin challenging its proposed role as IAP during mi-
tosis [41-43].
Our investigations reveal that the primary effect of the
knockdown of Survivin, i.e. polyploidy and defective
chromosomal segregation, develops independently from
p53 and leads to DNA double strand breaks followed by
DDR and enhanced chromosomal instability (Figure 8d).
We conclude that the loss of Survivin at kinetochores in
conjunction with multipolar spindles dramatically in-
creases the likelihood of merotelic spindle kinetochore
assemblies which cannot be resolved and finally leads to
disrupted chromosomes. Yet, the DDR resulted in a
transient p53/p21waf/cip –mediated cell cycle arrest in G1
and cells managed to repair DSBs through NHEJ recom-
bination. In line with this, the inhibition of another
chromosomal passenger protein, Aurora-B, recapitulated
Figure 8 ATM and DNA-PKCS induce cell cycle arrest after Survivin-RNAi. a: Western blot analysis of HCT116 and HCT116
shATM total cell
lysates following Survivin-RNAi (shSurv). Included are shLuc-transduced cells as control. Red values indicate densitometric estimation of protein
levels, normalized to Tubulin. b: Indirect immunofluorescence analysis of transduced SBC-2 cells showing colocalisation of activated ATM (ATM
S1981) and activated DNA-PK kinase (DNA-PKCS T2609) in shSurv polyploid cells. c: Western blot of HCT116 and HCT116
p53−/− cell lysates showing
analysis of p53 phosphorylation sites after Survivin knockdown. d: Proposed outline of Survivin RNAi phenotype and the observed DNA-damage
response signaling. e: Analysis of HCT116 and HCT116shATM cells transduced with shSurv and combined treatment with DNA-PKCS inhibitor
(DNA-PK-I, 10 μM Nu7026) or DMSO. Note combined inhibition of ATM and DNA-PKcs results in a decreased accumulation of p53 and p21
waf/cip
protein levels and reduction of γH2AX levels.
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The fact that the transient p53/p21waf/cip-dependent
cell cycle arrest was exclusively due to induction of a
DNA damage response and not connected to the loss of
IAP function of Survivin was proven by simultaneous in-
hibition of sensor kinases DNA-PK and ATM, which
abolished activation of p53 and induction of p21waf/cip.
Our results have profound implications concerning a
possible postmitotic G1 cell cycle arrest of tetraploid cells.
Recent reports suggested a p53 dependent G1 checkpoint
preventing tetraploid cells to enter S phase [44]. Until
now, it has remained entirely unknown by which mechan-
ism cells respond to tetraploidy in a p53-dependent man-
ner. In particular, the results from our BrdU-incorporation
assays suggest that tetraploidy occurring in cells with de-
fective CPC but functional p53 does not prevent progres-
sion into the next S-phase. Although a significant
fraction of cells suffer DSBs caused by poly-merotelic
kinetochore assemblies, they managed to repair DSBs
during a transient p53/p21waf/cip-mediated arrest and
progressed in their cell cycle. If the same transient or
eventually a stable cell cycle arrest occurs in tetraploid
cells having an intact CPC or in cells with defects in the
SAC remains to be investigated.
The potential role of Survivin in radioresistance and
tumor progression
Survivin has also been implicated in radiation resistance
of tumor cells. After radiation Survivin accumulates in
interphase nuclei of glioblastoma and colorectal carcin-
oma cells [45-47]. So far, the underlying mechanisms
how Survivin protects cells from radiation is still not
fully understood. It has been shown that interfering Sur-
vivin’s function by adenoviral overexpression of a
dominant-negative mutant of Survivin (SurvivinT34A)
leads to decreased DNA damage repair capacity in pri-
mary glioblastoma cells as detected by a DNA comet
assay [45]. Furthermore, siRNA of Survivin leads to a de-
creased activity of DNA-PKCS in LN229 glioma cells
after radiation and to a concomitant increase in residual
γH2AX foci per nucleus [46]. Strikingly, the same group
mentioned in their supplementary data increased levels
of phospho-ATM in non-irradiated SW480 colorectal
carcinoma cells after Survivin-RNAi, which is in line
with our results [47]. However, how the knockdown of
Survivin affects repair of DSB after radiation still re-
mains elusive since our SKY analysis shows that DNA
repair, in particular NHEJ, does not require Survivin and
does not even depend on p53.
So far the IAP function of Survivin in conjunction with
increased expression levels in tumors has also been impli-
cated to confer resistance to cellular stress and chemo-
therapy by inhibiting caspases [48], smac/DIABLO [9] andapoptosis inducing factor (AIF) [49]. In particular, ectopic
overexpression of Survivin in the skin of transgenic mice
has been described to confer resistance to UV-mediated
apoptosis but also resulted in enhanced progression of
skin tumors [50,51]. Various scientific articles emphasized
a possible role of the IAP function of Survivin in tumor
progression [52,53]. Yet, some studies demonstrated that
overexpression of Survivin also results in a higher fre-
quency of polyploid bone marrow and glioma cells
[24,54]. Furthermore, a low frequency of polyploid cells
was detected in normal human lung fibroblasts and
CD34-positive hematopoetic stem cells with ectopic over-
expression of Survivin [24]. Up to now, it is well known
that the deregulated expressions or the altered stoichiom-
etry of mitotic regulators, in particular Survivin’s partner
Aurora B, increase the risk for carcinogenesis by induction
of polyploidy and subsequent aneuploidy [55,56]. As a
result of our study and in conjunction with recent re-
ports describing that the overexpression of Survivin fa-
vors the progression from chemically induced papilloma
to squamous cell carcinoma in K14-Survivin transgenic
mice [57] and initiates hematological malignancies in
GATA1-Sur transgenic mice after a single intraperito-
neal injection of tumor promoting N-ethyl-nitrosourea
[58], it appears also conceivable that besides Survivin’s
IAP function deregulations in the mitotic function of
Survivin favor the development of aneuploid cells. In the
future it might be therefore worthwhile to investigate the
impact of deregulated Survivin protein expression levels
on genetic stability and carcinogenesis.
Conclusions
In summary, we have investigated in depth the role of
Survivin in control of chromosome segregation and
chromosomal stability. Our data indicate that a transient
p21waf/cip –mediated cell cycle arrest after knockdown of
Survivin is not connected to a proposed IAP function in
mitosis, but instead represents a DDR phenotype linked
to its role as CPP. Paradoxically our results indicate that
p53 expression does not prevent aneuploidy when inter-
fering with Survivin’s CPP function. Therefore, Survivin
and its molecular partners in the CPC fundamentally
control genetic stability of cells.
Material and methods
Cell culture and clonogenic survival
The hypodiploid colorectal carcinoma-derived HCT116
cells (kindly provided by B. Vogelstein, Johns Hopkins
University, Baltimore) were cultured in RPMI medium
(Life Technologies) supplemented with 10% FCS, 2 mM L-
glutamine, 10 mM Hepes, 100 U/ml penicillin and 100 μg/
ml streptomycin, whereas the near triploid cervix carcin-
oma cell line SBC-2 and the human embryonic kidney
cells 293 T were maintained in Dulbecco’s modified Eagle
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supplemented with 10% FCS, 10 mM HEPES, 100 U/ml
penicillin and 100 μg/ml streptomycin. The diploid
glioblastoma- derived U87-MG cell line and cultivation
has been described before [59]. All cell lines were au-
thenticated (Multiplexion GmbH, Heidelberg, Germany)
and cultured at 37°C with 5% CO2. Clonogenic survival of
transduced U87-MG, HCT116, SBC-2 cells and p53-
deficient counterparts was tested by plating duplicates of
1000 cells/dish for every vector transduction onto 10 cm
dishes. After 3 weeks, cells were stained with Giemsa and
the number of clones was quantified. At least two inde-
pendent experiments with similar results were performed
for each cell line. For DNA-PKcs inhibition cells were
cultured, transduced and selected as described. 6 hours
before cell lysis media containing 10 μM Nu7026 (Selleck-
chem) or DMSO were added to the cells.
Retroviral shRNA vectors and transduction
For knockdown of target RNAs we used self-inactivating
retroviral Moloney murine leukemia virus (MoMuLV)
backbones pRVH-1-puro and pRVH-1-Hygro, both con-
taining a H1 polymerase III promoter for the expression
of shRNA molecules. All DNA oligonucleotides encoding
shRNAs were synthesized with appropriate BamH I and
Sal I restriction sites (Eurofins MWG Biotech) to allow
ligation into pRVH-1 vectors. For knockdown of Survivin
we used the recently described small hairpin RNA shSur-
vivin#433 [26] ligated into pRVH-1-puro. For the gener-
ation of U87-MGshp53, SBC-2shp53 and HCT116shATM cells
we used the shRNAs shp53 (upper strand: 5′-gatccccgac
tccagtggtaatctacttcaagagagtagattaccactggagtctttttggc − 3′,
bottom strand: 5′-tcgagccaaaaagactccagtggtaatctactctctt
gaagtagattaccactggagtcggg − 3′ [60]) and shATM (upper
strand: 5′-gatccccgataccagatccttggagattcaagagatctccaaggat
ctggtatctttttggc − 3′, bottom strand: 5′-tcgagccaaaaaga
taccagatccttggagatctcttgaatctccaaggatctggtatcggg − 3′ [61])
ligated in pRVH1-Hygro. As negative control, a previ-
ously described RNA targeting sequence for luciferase
mRNA (shLuc) was included during all experiments
[59]. Transduction of retroviral shRNA vectors was per-
formed as described previously [26]. For the generation
of stable p53- (shp53) or ATM- (shATM) deficient cells,
transduced cells were selected and cultured using
300 μg/ml Hygromycin B (Life Technologies).
Indirect immunofluorescence analysis
Cells grown on glass slides were fixed for 20 min with
4% PFA. Then they were washed three times for 5 min
in HBSS and stained with WGA-Texas Red (wheat germ
agglutinin; Life Technologies) in HBSS (10 μg/ml) for
10 min followed by a permeabilization step with 5%
BSA, 0.3% Triton-X-100 in PBS for 30 min. Cells were
incubated with a primary antibody solution (5% BSA inPBS) for 2 h including monoclonal mouse anti-α-
Tubulin (Sigma), monoclonal rabbit anti-p21waf/cip (Cell
Signaling), monoclonal rabbit anti-CHK2 T68 (Cell Sig-
naling), monoclonal rabbit anti-ATM S1981 (Epitomics),
monoclonal mouse anti-γH2AX (Millipore) and mono-
clonal mouse anti-DNA-PKCS T2609 (Abcam), respect-
ively. After three 5-min-washes with PBS, cells were
subsequently incubated with a secondary antibody solu-
tion (sheep/goat anti-mouse Cy3-conjugated antibody,
Dianova; sheep/goat anti-rabbit FITC-conjugated anti-
body, Dianova) for 1 hour followed by extensive wash
cycles in HBSS. DNA counterstaining was accomplished
using HBSS-Hoechst 33342 (0.1 μg/ml, Life Technolo-
gies) solution. Finally, cells were washed twice in HBSS
and once in double distilled water, prior the examination
by confocal laser scanning microscopy. Colocalization
analyses (Coloc) were performed using Fiji’s “Colocaliza-
tion” algorithm. The p21waf/cip and ɣH2AX statistics
were calculated after analyzing the average percentage
of fluorescence-labeled cells in at least 3 random fields
of shLuc-transduced cells and 6–17 random fields of
shSurv-transduced cells, representing at least 570 cells
per group. Statistical analysis was performed using Stu-
dent’s t-test.
Detection of merotelic kinetochore-microtubuli
assemblies
Cells were rinsed with HBSS and stained with WGA-
Texas Red in HBSS (10 μg/ml) for 10 min at 37°C
followed by an incubation with Ca2+ buffer (100 mM
PIPES pH 6.8; 1 mM MgCl2; 1 mM CaCl2; 0.5% Triton-
X-100) for 7 min at 37°C and fixation with 4% PFA in
PBS for 20 min at room temperature. After three 5-min-
washes in PHEM buffer pH 6.9 (60 mM PIPES; 25 mM
HEPES; 10 mM EGTA; 2 mM MgCl2), cells were perme-
abilized (5% BSA in PHEM; 0.3% Triton-X-100) for
30 min at room temperature, subsequently washed three
times for 5 min in PHEM buffer and were then incu-
bated at room temperature with the primary antibodies
in blocking solution (5% BSA in PHEM buffer). Anti-
bodies include mouse anti-α-Tubulin (1:1000; 1.5 h;
Sigma) and human anti-centromeric antibody (ACA, 1:500,
kindly provided by K. Conrad, TU Dresden, Germany). The
primary antibodies were detected after three 5 min washes
(PHEM buffer) with polyclonal sheep anti-mouse-Cy3
(1:100; 1 h; Dianova) and anti-human-FITC (undiluted;
30 min; AKLIDES ANA plus; Medipan) successively in
blocking solution at room temperature in the dark. After
three 5-min-washes in HBSS, DNA was counterstained
with Hoechst 33342 (0.1 μg/ml).
Stained cells were imaged with a Leica SP5 inverse
microscope (Leica, Wetzlar, Germany). Confocal images
were collected at 405, 488, 543 and 594 nm with 63x
NA1.4 or 40x NA1.25 objective lenses. Image acquisition,
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were all controlled by Leica LAS AF software. Series in z-
directions (Z-stacks) of single cells were obtained at
0.3 μm steps. Equivalent exposure conditions and scaling
was used between controls and RNAi-depleted cells. Im-
ages were analyzed using Fiji software [62] (http://fiji.sc/
Fiji). For analysis of merotelic attachments, the acquired
images were processed in Fiji including background sub-
traction, contrast enhancement, smoothing and 3D recon-
struction. A kinetochore was scored as being merotelic
when it clearly connected two or more visible spindle fi-
bers emanating from different poles in a z-stack or recon-
structed 3D image.
Western blot analysis
Cells were harvested and lysed in lysis buffer (10 mM
Tris–HCl pH 8.0; 140 mM NaCl; 1% Triton-X-100).
Equal amounts of proteins were loaded onto SDS poly-
acrylamide gels, separated by gel electrophoresis and
blotted onto PVDF membranes. Subsequently, mem-
branes were washed 3 times for 10 min in TBS plus 2%
Triton X-100 and 0.5% Tween 20 (TBS-TT) and blocked
with 5% milk powder or BSA. The membranes were
probed with primary antibodies in blocking solution over
night at 4°C including rabbit polyclonal anti-Survivin
(R&D Systems), polyclonal mouse anti-p21waf/cip (R&D
Systems), monoclonal rabbit anti-p21waf/cip (Cell Signal-
ing), polyclonal goat anti-p53 (R&D Systems), monoclo-
nal rabbit anti-p53 S15 (Abcam), polyclonal anti-p53
S20, polyclonal anti-p53 S37 (Cell Signaling), monoclo-
nal mouse anti-α-Tubulin and monoclonal anti-Actin
(Sigma), monoclonal rabbit anti-ATM S1981 (Epitomics),
polyclonal rabbit anti-ATM (Merck), monoclonal rabbit
anti-Caspase 3 (Cell Signaling), monoclonal rabbit anti-
CHK2 T68 (Cell Signaling), polyclonal rabbit anti-Cyclin
D1 (Santa Cruz), polyclonal rabbit anti-Cyclin E (Santa
Cruz) and monoclonal mouse anti-γH2AX (Millipore).
After incubation with the primary antibodies, the mem-
branes were washed three times with TBS-TT and incu-
bated for 1 hour at room temperature with appropriate
secondary antibodies conjugated with HRP (Dako). The
membranes were washed again and signal detection
was carried out by chemiluminescence (Luminata Forte,
Millipore) using a LAS3000 device. Western blots were
quantified with Fiji’s “Gel Analyzer Tool” and densitomet-
ric values were normalized to Tubulin.
Flow cytometry
Cell cycle and apoptosis was determined in a flow cyt-
ometer using PI-stained cells as described previously
[26]. Analysis of raw data was performed using FlowJo
software (Tristar, Inc.). For combined DNA-antibody
staining 2 x 105 cells/sample were permeabilized and
blocked using 5% BSA in PBS plus 0.3% Triton X-100for 30 min at room temperature. After centrifugation
(1500 rpm, 4°C, 5 min) supernatant were discarded and
cells incubated with monoclonal rabbit anti-p21waf/cip
(Cell Signaling), polyclonal rabbit anti-Cyclin D1 (Santa
Cruz), monoclonal mouse anti-γH2AX (Millipore), poly-
clonal rabbit IgG (Santa Cruz) or monoclonal mouse
IgG1 (Millipore) respectively, diluted in blocking solu-
tion for 2 h at room temperature. Primary antibodies
were detected using FITC-conjugated goat anti-rabbit or
FITC-conjugated sheep anti-mouse (Dianova) antibodies
for 1 h at room temperature. Finally, DNA was counter-
stained with 20 μg/ml PI and 40 μg/ml RNase A in PBS
for 30 min at room temperature in the dark.
For DNA-synthesis analysis cells were incubated with
10 μM BrdU (Sigma) and analyzed as described previ-
ously [26]. FACS data processing includes doublet dis-
crimination and debris exclusion. All experiments were
performed at least three times with similar results. Statis-
tical analysis was performed with Student’s t-test. Annexin
V staining has been performed according to manufacturer
instruction (Life Technologies). Briefly, cells were washed
once in PBS and trypsinized. After centrifugation (300 g,
8 min, 4°C) supernatant was removed and cells were
washed again with PBS followed by re-centrifugation.
Then, cell pellet (maximum 106 cells) was resuspended
in 100 μl of annexin V binding buffer and 5 μl of
annexin V were added. After an incubation period of
15 min at room temperature samples were diluted with
400 μl of annexin V binding buffer and re-centrifuged.
Finally, cell pellets were resuspended in 100 μl annexin V
binding buffer. PI (1 μg/ml, Miltenyi) was automatically
added right before FACS measurement using MACS-
Quant analyzer (Miltenyi).
Cytogenetic analyses
HCT116p53−/− shLuc and shSurv cells were analyzed
using Spectral karyotyping (SKY), DAPI and Giemsa-
staining. For preparation of metaphase chromosomes 72 h
after transduction methotrexate (5 μg ml) was added for
further 17 hours. Medium was removed and cells incu-
bated in fresh medium with 150 μl BrdU-FUdR-solution
at 37°C for 5 h. Cells were treated with colcemid for
60 min at a concentration of 0.035 μg/ml, incubated in
75 mM KCl for 20 minutes at 37°C, and fixed in a freshly
prepared mixture of methanol/acetic acid (3:1) at room
temperature. Cell suspension was dropped onto glass
slides. Spectral karyotyping (SKY) analysis was performed
as described previously [63]. SKY images of about at least
20 metaphase chromosomes per cell line stained with a
mixture of 5 fluorochromes were captured using an
DMRXA epifluorescence microscope (Leica GmbH,
Wetzlar, Germany), HCX PL SAPO 63x/1.30 oil objective
(Leica), SpectraCube® system (Applied Spectral Imaging,
Migdal HaEmek, Israel), and SKYView® imaging software
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mosomes were stained with DAPI and Giemsa and num-
ber of chromosomes (ploidy), chromosomal breaks, and
chromosomal aberrations (ring and dicentric chromo-
somes) per metaphase were counted. Statistical analysis
was performed with Student’s t test. Mann–Whitney-U
test was carried out to compare frequencies of breaks as
well as ring and dicentric chromosomes.
Additional files
Additional file 1: This figure shows efficiency of p53 knockdown
and response to doxorubicin treatment in U87-MG and SBC-2 cells.
Western blot analysis showing the knockdown of p53 in glioma and
cervix cancer tumor cells. Note that U87-MG and SBC-2 cells accumulate
p53 in response to DNA-damaging doxorubicin treatment (0.25 μg/ml)
whereas no increase of p53 is observed in U87-MGshp53 and SBC-2shp53
cells.
Additional file 2: This figure shows clonogenic survival assays,
analysis of caspase 3 cleavage and quantitative analysis of cell
death after knockdown of Survivin. a: Analysis of clonogenic survival
of shSurv-transduced HCT116, U87-MG and SBC-2 cells and isogenic cells
with knock out and knockdown of p53, respectively. Note the strong
decrease in clonal survival in all cell lines after Survivin knockdown when
compared to the shLuc controls. The experiments were repeated twice
with similar results. b-c: Western blot analysis of Caspase 3 activation
following knockdown of Survivin in (b) U87-MG, U87-MGshp53 (72 h) and
(c) HCT116, HCT116p53−/− cells at different time points. As control, a total
cell lysate from HCT116 cells treated with apoptosis-inducing C2
ceramide (100 μm) is included. d: Quantitative analysis of FACS-assisted
DNA-measurements of HCT116, SBC-2 and U87-MG cells and corresponding
p53-deficient isogenic cells with knockdown of Survivin or transduction with
shLuc control vector. Note the increase in the SubG1-fractions (dead cells)
in shSurv-transduced HCT116 and SBC-2 cells when compared to the
corresponding shLuc-transduced control cells. (*p < 0.05; **p < 0.01; n = 4).
e: Representative images of annexin V – PI stained HCT116 cells 72 h after
transduction of shLuc or shSurv, respectively. For apoptosis induction cells
were incubated for 24 h with 5 μg/ml puromycin. f: Quantitative analysis of
annexin V stained HCT116 and HCT116p53−/− cells transduced with shRNAs
targeting Survivin (shSurv) or Luciferase (shLuc) at different time points.
Control, HCT116 cells treated for 24 h with 5 μg/ml puromycin; apoptotic
cells (annexin V+, PI-); dead cells (annexin V+, PI+; annexin V-, PI+). Data
represents mean values and SEM of two independent experiments.
Additional file 3: This movie file shows a merotelic kinetochore
spindle assembly in SBC-2 cell with knockdown of Survivin. This
movie shows Z-stacks through a merotelic-attached kinetochore in a
SBC-2 cell with knockdown of Survivin. Kinetochores (red) and
microtubules (white) were visualized using anti-centromer antibodies
(ACA) and a monoclonal anti-Tubulin antibody.
Additional file 4: This figure illustrates numeric and structural
chromosomal aberrations following Survivin-RNAi: DAPI-stained
metaphase of HCT116p53−/− cells with knockdown of Survivin
showing a near hypohexadecaploid (16n) karyotype with dicentric
chromosomes (arrows) and ring chromosomes (arrowhead, see
magnified regions).
Additional file 5: This figure depicts site specific accumulation of
activated ATM at DNA lesions in U87-MG cells with knockdown of
Survivin. a: Images of U87-MG cells, with knockdown of Survivin and
stained for activated ATM S1981 and ɣH2AX. Inlet showing magnification
of indicated multinucleated cell with colocalized ɣH2AX and ATM S1981.
b: Representative image depicting ɣH2AX and ATM S1981 staining results
in shLuc-transduced controls. Colocalization analyses (Coloc) were
performed using Fiji’s “Colocalization” algorithm. Magnification bars: 10 μm.
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